MA33351B1 - Formes stables du n-(2,6-diméthyl-4-morpholin-4-ylphényl)-3,3-diméthylbutyramide - Google Patents

Formes stables du n-(2,6-diméthyl-4-morpholin-4-ylphényl)-3,3-diméthylbutyramide

Info

Publication number
MA33351B1
MA33351B1 MA34435A MA34435A MA33351B1 MA 33351 B1 MA33351 B1 MA 33351B1 MA 34435 A MA34435 A MA 34435A MA 34435 A MA34435 A MA 34435A MA 33351 B1 MA33351 B1 MA 33351B1
Authority
MA
Morocco
Prior art keywords
dimethyl
morpholine
phenyl
stable form
dimethylbutyramide
Prior art date
Application number
MA34435A
Other languages
Arabic (ar)
English (en)
Inventor
Svend Treppendahl
Karin Liltorp
De Diego Heidi Lopez
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42237259&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA33351(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of MA33351B1 publication Critical patent/MA33351B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

L'invention porte sur des formes polymorphes du N-(2,6-diméthyl-4-morpholin-4-ylphényl)-3,3-diméthylbutyramide ainsi qu'un procédé pour la fabrication dudit composé.
MA34435A 2009-05-11 2010-05-11 Formes stables du n-(2,6-diméthyl-4-morpholin-4-ylphényl)-3,3-diméthylbutyramide MA33351B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200900597 2009-05-11
PCT/DK2010/050101 WO2010130260A2 (fr) 2009-05-11 2010-05-11 Formes stables du n-(2,6-diméthyl-4-morpholin-4-ylphényl)-3,3-diméthylbutyramide

Publications (1)

Publication Number Publication Date
MA33351B1 true MA33351B1 (fr) 2012-06-01

Family

ID=42237259

Family Applications (1)

Application Number Title Priority Date Filing Date
MA34435A MA33351B1 (fr) 2009-05-11 2010-05-11 Formes stables du n-(2,6-diméthyl-4-morpholin-4-ylphényl)-3,3-diméthylbutyramide

Country Status (23)

Country Link
EP (1) EP2430008A2 (fr)
JP (1) JP2012526152A (fr)
KR (1) KR20120022934A (fr)
CN (1) CN102459208A (fr)
AR (1) AR076556A1 (fr)
AU (1) AU2010246724B2 (fr)
BR (1) BRPI1013930A2 (fr)
CA (1) CA2761383A1 (fr)
CL (1) CL2011002814A1 (fr)
CO (1) CO6460741A2 (fr)
CR (1) CR20110590A (fr)
DO (1) DOP2011000351A (fr)
EA (1) EA201171381A1 (fr)
GE (1) GEP20146006B (fr)
IL (1) IL216148A0 (fr)
MA (1) MA33351B1 (fr)
MX (1) MX2011011885A (fr)
NZ (1) NZ596738A (fr)
SG (1) SG175968A1 (fr)
TN (1) TN2011000557A1 (fr)
TW (1) TW201041857A (fr)
WO (1) WO2010130260A2 (fr)
ZA (1) ZA201108112B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119490430A (zh) 2019-08-02 2025-02-21 H.隆德贝克有限公司 用于在癫痫或癫痫发作中使用的作为Kv7钾通道开放剂的醇衍生物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI349666B (en) * 2004-03-12 2011-10-01 Lundbeck & Co As H Substituted morpholine and thiomorpholine derivatives
BRPI0716715B1 (pt) * 2006-08-23 2021-07-06 Xenon Pharmaceuticals, Inc Derivados de 4-(n-azacicloalquil) anilidas como moduladores de canal de potássio, seus usos, produto, composição, comprimido e cápsula
EP2185149A1 (fr) * 2007-08-01 2010-05-19 H. Lundbeck A/S Utilisation d'agents d'ouverture kncq des canaux potassiques pour réduire des symptomes ou traiter des troubles et des états dans lesquels le système dopaminergique est détruit

Also Published As

Publication number Publication date
SG175968A1 (en) 2011-12-29
IL216148A0 (en) 2012-01-31
TW201041857A (en) 2010-12-01
BRPI1013930A2 (pt) 2019-09-24
CA2761383A1 (fr) 2010-11-18
NZ596738A (en) 2013-04-26
CN102459208A (zh) 2012-05-16
EP2430008A2 (fr) 2012-03-21
WO2010130260A2 (fr) 2010-11-18
JP2012526152A (ja) 2012-10-25
MX2011011885A (es) 2011-12-06
TN2011000557A1 (en) 2013-05-24
CO6460741A2 (es) 2012-06-15
AR076556A1 (es) 2011-06-22
KR20120022934A (ko) 2012-03-12
CL2011002814A1 (es) 2012-04-13
WO2010130260A3 (fr) 2011-06-16
GEP20146006B (en) 2014-01-10
AU2010246724A1 (en) 2011-12-08
EA201171381A1 (ru) 2012-05-30
CR20110590A (es) 2012-02-22
WO2010130260A9 (fr) 2012-10-18
ZA201108112B (en) 2013-01-30
DOP2011000351A (es) 2012-01-31
AU2010246724B2 (en) 2013-03-21

Similar Documents

Publication Publication Date Title
EP2093223A4 (fr) Procédé de fabrication d'un composé anthranilamide
EP1991499A4 (fr) Procédé de synthèse non métallique de nanocircuits semi-conducteurs épitaxiques sur du si
EP2548862A4 (fr) Procédé de fabrication d'un composé amide
EP2297033A4 (fr) Procédé pour la fabrication de carbure de silicium
EP2149545A4 (fr) Procédé de production d'un composé benzaldéhyde
EP2474560A4 (fr) Procédé de production d'un sialyloligosaccharide à 11 sucres-peptide
EP2130583A4 (fr) Procédé de fabrication d'un composé carbonyle
EP2230333A4 (fr) Procédé destiné à faire croître un cristal de nitrure d'aluminium, procédé de fabrication du cristal de nitrure d'aluminium et cristal de nitrure d'aluminium
MY146084A (en) Benzyl amines, a process for their production and their use as anti-inflammatory agents
EP2174927A4 (fr) Procédé de production d'un composé de beta-nitrostyrène
EP2442928A4 (fr) Installation à haut rendement pour fabrication d'acier
EP2213656A4 (fr) Procédé de fabrication d'un composé de cyanhydrine et procédé de fabrication d'un composé alpha-hydroxyester
EP2143718A4 (fr) Procédé de production d'un composé tétraglycidylamino
EP2627620A4 (fr) Procédé intégré pour la fabrication d'oléfines fluorées
EP2014634A4 (fr) Procédé pour la production d'oléfines cycliques
EP2398926A4 (fr) Procédé de fabrication de produits à base de carbure métallique
EP1944376A4 (fr) Procédé de production d'un composé amide
EP2256102A4 (fr) Procédé de fabrication d'un composé alcoxycarbonyle
EP1834949A4 (fr) Composé diépoxy alicyclique de pureté élevée et procédé servant à produire celui-ci
EP2415741A4 (fr) Procédé de fabrication d'un composé alcool
EA200870038A1 (ru) Способ получения аминов
EP2154123A4 (fr) Procédé de production d'un composé benzaldéhyde
EP1813596A4 (fr) Procédé de synthèse d'une alpha, alpha-difluoroamine
EP2077261A4 (fr) Procédé servant à produire un composé succinimide
EP2514783A4 (fr) Procédé pour la production d'un composé d'organopolysiloxane